Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Sample Management and Batch sending Process of Drug Products for Nitrosamines

A French multi-national Pharmaceutical Company required support in the Nitrosamines Project in describing a process for Sample Management and Batch sending Process. Defining the process for sample management and the batch sending process for drug products being tested for nitrosamines required clear, compliant workflows. These workflows must align with regulatory requirements (e.g., EMA, FDA, ICH) and internal quality standards.

Challenges Faced

A detailed GAP analysis in Quality Management Systems is essential for identifying process deficiencies effectively.
  • Regulatory Scrutiny: The transport and storage of drug products, including those being tested for nitrosamines, must comply with regulatory standards to ensure product integrity and quality throughout the supply chain. In addition, the regulations for specific countries must be
  • Document Volume: Documentation is a critical component of the sample management and batch sending process for drug products, ensuring compliance with regulatory standards, maintaining traceability, and providing evidence of quality control activities. This had to be set up to support the Process.
  • Time Sensitivity: To ensure the shipment of drug products to an analytical testing site within the required time frame while maintaining product integrity, the shipment process must be carefully planned, documented, and executed in compliance with regulatory standards.

Zamann Pharma Support’s Approach

  • Project Initialization: Zamann initiated the planning of Sample Management and the Batch Sending Process of drug products for nitrosamine testing involves detailed preparation to ensure compliance with regulatory standards, maintain sample integrity, and streamline workflow efficiency. A cross-functional team was defined to include all aspects such as Quality Assurance, Analaytical Laboratory; Supply Chain/Logistics; Regulatory Affairs and Manufacturing.
  • Documentation: The correct Documentation was defined and prepared for the Process as it is critical to ensure compliance, traceability, and overall product quality. Also in order to ensure that there is traceabilitiy and Batch identifcation for the batches available.
  • Key Topics Evaluated: The key topics were outlined and evaluated such as Regulatory and Quality Compliance; Risk Assessment and Planning; Sampling Processes; Documentation and Records; Transport and Storage and Analytical Testing Coordination. Zamann defined a process that would incorporate all the Topics mentioned above.
  • Support for Implementation: Meetings were coordinated with the manufacturing team to provide targeted training on the Sample Management and Batch Sending Process, ensuring they understood sampling, labeling, and handling requirements. These sessions also focused on organizing SharePoint platforms for streamlined access to relevant documents, including SOPs, templates, and records. Clear responsibilities and workflows were established, promoting efficient documentation and alignment with regulatory standards.

Results Achieved

  • Regulatory Compliance: The alignment of the Sample Management and Batch Sending Process ensured that drug products were prepared, documented, and shipped in compliance with protocols, enabling timely delivery to the analytical site. Streamlined workflows, proper labeling, and coordination between teams minimized delays, maintaining sample integrity and supporting efficient nitrosamine testing within the required timeframe.
  • Improved Documentation: The client’s documentation was streamlined, making it easier to manage, review, and present during inspections.
  • Team Empowerment: Clear communication with all stakeholders was essential to establish a well-coordinated Sample Management and Batch Sending Process for nitrosamine testing. Regular updates, defined roles, and transparent expectations ensured alignment between manufacturing, quality assurance, supply chain, and analytical teams. This collaboration facilitated compliance with protocols, timely actions, and the seamless transfer of drug products to the testing site.
Laboratory
Pharmaceutical quality team reviewing nitrosamines risk assessment documentation aligned with ICH M7 and current regulatory compliance requirements
Services

Nitrosamines Regulatory Compliance

We assist pharmaceutical teams in assessing and managing nitrosamines risks by aligning processes with ICH M7 requirements and current regulatory expectations.

Read More

Contact Us

Need help? Don't hesitate to get in touch
Zamann pharma support is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

FAQ

1. How do quality teams ensure traceability when shipping drug product samples for nitrosamine analysis across external laboratories?

Teams establish a structured sample lifecycle system that assigns a unique identifier to every batch before shipment. First, they link each sample to manufacturing records, labeling data, and testing intent. Then, they enforce controlled handover documentation between supply chain and analytical sites. As a result, full traceability remains intact from production to laboratory receipt, supporting regulatory expectations under EMA and FDA frameworks.

2. What is the most effective way to prevent sample integrity loss during time-sensitive transport for impurity testing?

The most effective method is to define pre-approved transport conditions within a validated sample management protocol. In addition, teams monitor packaging, temperature requirements, and maximum holding times before dispatch. Therefore, they minimize degradation risks during transit and ensure analytical results reflect true product quality rather than handling variability.

3. How do pharmaceutical companies manage documentation overload in batch sending workflows for regulatory impurity testing projects?

Companies reduce documentation burden by standardizing templates and centralizing all shipment-related records in a controlled digital repository. Moreover, they align documentation steps with predefined SOPs covering sampling, labeling, and shipment approval. Consequently, teams eliminate redundant manual entries and maintain inspection-ready records that support audit traceability and regulatory compliance.